Arcellx, Inc. (ACLX)

66.07 +0.56 (+0.85%) USD  |  NASDAQ  |  Dec 24, 12:59
66.05 -0.02 (-0.03%) After-Hours: 13:59
More

Arcellx CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Bristol Myers Squibb Co. Upgrade
Geron Corp. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade